News & Events
A Doctor Just for Girls
Beth Schwartz joins Jefferson and Nemours as a specialist in pediatric and adolescent gynecology to help families address girls’ needs from birth to early adulthood.
Arteries Better Than Veins for Liquid Biopsy
Arteries contain higher numbers of circulating tumor cells than veins in uveal melanoma patients, raising a concern for standard technique for detection of tumor cells in the blood.
One Size Doesn’t Fit All: Patients with Metastatic Cancer May Need Stronger Anti-Coagulation Therapy Following Bone Lesion Surgery
Jefferson researchers identified a high risk for venous thromboembolism (VTE), or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer.
Genomic Analysis for All Cancer Patients
Jefferson expands its cancer treatment to analyze each cancer patient's tumor with the newest techniques and help doctors identify cutting edge treatment options.
Simple Test Predicts Obstructive Sleep Apnea in Patients Hospitalized for Heart Failure
Sunil Sharma, M.D. and his team showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure.
High Use of Alternative Medicine in Senior Oncology Patients
Many seniors with cancer are also using complementary or alternative medicines that could interfere with their cancer treatment.
Thomas Jefferson University Launches Interactive Curricula Experience
New Curriculum Platform uses iPads to Meet Students Where They Are – On Mobile Devices
Jefferson Physician and Researcher Named Next President of the National Medical Association
Edith Mitchell, M.D., Professor of Medical Oncology at Thomas Jefferson University, will be appointed as President of the National Medical Association (NMA) at the NMA’s 113th Annual Convention and Scientific Assembly in Detroit, Michigan on Tuesday August 4th.
Genomic Fingerprint May Predict Aggressive Prostate Cancer in African Americans
A set of genes could help stratify African American men in need of more aggressive treatment for prostate cancer.
Lynchpin Molecule for the Spread of Cancer Found
A single molecule called DNA-PKcs may drive metastatic processes that turn cancer from a slowly growing relatively benign disease to a killer.